Biogen Idec U.S.Corp.

Antegren's Miss In Crohn's Mars Respectable Earnings For Biogen.
BIOWORLD Today; 11/4/2009; 1311 words; ...second quarter and - with Biogen estimating between $50 million...middle, at $59 million. Biogen reconfirmed its full-year...though, the biggest thing on Biogen's horizon is its pending merger with IDEC Pharmaceuticals Corp., of San

Other News To Note.
BIOWORLD Today; 11/4/2009; 1781 words; ...of James Vincent, Biogen's former CEO and chairman...marketable securities. Biogen attributed the falling...from Serono SA's drug, Rebif. Deltagen...among other things. IDEC Pharmaceuticals Corp., of San Diego...per share. Rituxan U.S. revenues were...

Phase II Patient's Blood Clot Halts IDEC Antibody Trials.
BIOWORLD Today; 11/4/2009; 1177 words; ...Washington Editor IDEC Pharmaceuticals Corp.'s stock dipped Tuesday...monoclonal antibody, IDEC-131, after one...Mass.-based Biogen Inc. stopped Phase...Reardon said. IDEC partnered Zevalin...sales outside the U.S. The worldwide...

FoldRx Kicks Off Phase II/III Against Genetic Neuropathy.
BIOWORLD Today; 11/3/2009; 1162 words; ...after diagnosis. "It's a very dramatic disease...designed to stop FAP's progression by blocking...000 people in the U.S., with the mutation...Genome Therapeutics Corp. (now Oscient Pharmaceuticals...news lately include Biogen Idec Inc., of Cambridge...

Biogen Idec Beats Estimates, Records $773M In Revenues.
BIOWORLD Today; 11/3/2009; 1001 words; ...recognizes product sales. U.S. net sales of Rituxan...sold through partner Elan Corp. plc in the U.S. (based on $46.8 million...As of mid-July, Biogen said, about 13,000 patients...James Mullen, Biogen Idec's CEO, said in a news...